Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morton Scheinberg

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Arthritis & Rheumatology (Hoboken, N.J.)|January 25, 2017
Efficacy and Safety of Subcutaneous Belimumab in Systemic Lupus Erythematosus: A Fifty-Two-Week Randomized, Double-Blind, Placebo-Controlled StudyWilliam Stohl, Andreas Schwarting, Masato Okada, et al.
Mabs|October 12, 2017
Variability of intended copies for etanercept (Enbrel®): Data on multiple batches of seven productsBrian Hassett, Morton Scheinberg, Gilberto Castañeda-Hernández, et al.
Revista Brasileira De Reumatologia|December 11, 2012
Anti-C1q, anti-chromatin/nucleosome, and anti-dsDNA antibodies in juvenile systemic lupus erythematosus patientsAdriana Almeida de Jesus, Lucia Maria Arruda Campos, Bernadete Lourdes Liphaus, et al.
Future Science OA|January 13, 2021
Immune manifestations with checkpoint inhibitors in a single Brazilian center: experience and literature reviewRafael A Schmerling, Antonio C Buzaid, Carolina K Haddad, et al.
Arthritis Care & Research|July 3, 2010
Abatacept improves health-related quality of life, pain, sleep quality, and daily participation in subjects with juvenile idiopathic arthritisNicolino Ruperto, Daniel J Lovell, Tracy Li, et al.
Lancet (London, England)|July 18, 2008
Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trialNicolino Ruperto, Daniel J Lovell, Pierre Quartier, et al.
The New England Journal of Medicine|July 5, 2018
Inotersen Treatment for Patients with Hereditary Transthyretin AmyloidosisMerrill D Benson, Márcia Waddington-Cruz, John L Berk, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Arthritis & Rheumatology (Hoboken, N.J.)|January 25, 2017
Efficacy and Safety of Subcutaneous Belimumab in Systemic Lupus Erythematosus: A Fifty-Two-Week Randomized, Double-Blind, Placebo-Controlled StudyWilliam Stohl, Andreas Schwarting, Masato Okada, et al.
Mabs|October 12, 2017
Variability of intended copies for etanercept (Enbrel®): Data on multiple batches of seven productsBrian Hassett, Morton Scheinberg, Gilberto Castañeda-Hernández, et al.
Revista Brasileira De Reumatologia|December 11, 2012
Anti-C1q, anti-chromatin/nucleosome, and anti-dsDNA antibodies in juvenile systemic lupus erythematosus patientsAdriana Almeida de Jesus, Lucia Maria Arruda Campos, Bernadete Lourdes Liphaus, et al.
Future Science OA|January 13, 2021
Immune manifestations with checkpoint inhibitors in a single Brazilian center: experience and literature reviewRafael A Schmerling, Antonio C Buzaid, Carolina K Haddad, et al.
Arthritis Care & Research|July 3, 2010
Abatacept improves health-related quality of life, pain, sleep quality, and daily participation in subjects with juvenile idiopathic arthritisNicolino Ruperto, Daniel J Lovell, Tracy Li, et al.
Lancet (London, England)|July 18, 2008
Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trialNicolino Ruperto, Daniel J Lovell, Pierre Quartier, et al.
The New England Journal of Medicine|July 5, 2018
Inotersen Treatment for Patients with Hereditary Transthyretin AmyloidosisMerrill D Benson, Márcia Waddington-Cruz, John L Berk, et al.
Pageof 7